PDR 2007

The authoritative source of FDA-approved information on prescription
drugs.
Physicians have turned to PDR for the latest word on prescription
drugs for over 60 years! Today, PDR is considered the standard
prescription drug reference and can be found in virtually every
physician뭩 office, hospital, and pharmacy in the United States. In
fact, nine out of 10 doctors consider PDR their most important drug
information reference source.
The 61st edition contains more than 3,000 pages뾬ur most
comprehensive edition ever! Our new format allows dramatically
improved readability and easier access to the information you need
now. Among the new drugs featured in this edition are:
Amitiza (lubiprostone), a new locally acting chloride-channel
activator for the oral treatment of chronic idiopathic constipation
in adults
Daytrana (methylphenidate transdermal system), a new once-daily
transdermal patch formulation of methylphenidate for the treatment of
attention deficit hyperactivity disorder
Nexavar (sorafenib), a new multi-kinase inhibitor for the treatment
of patients with advanced renal cell carcinoma
Proquad a new live vaccine for simultaneous vaccination against
measles, mumps, rubella (German measles) and varicella (chickenpox)
in children 12 months to 12 years of age (Proquad is also approved
for use in children 12 months to 12 years of age if a second dose of
measles, mumps, and rubella vaccine is to be administered)
Ranexa (ranolazine extended-release tablets), a new anti-anginal for
the treatment of chronic angina
Rotateq (rotavirus vaccine, live, oral, pentavalent), a new vaccine
for the prevention of rotavirus gastroenteritis in infants and
children
Sutent (sunitinib malate), a new multi-kinase inhibitor for patients
with advanced renal cell carcinoma, and gastrointestinal stromal
tumor after disease progression on, or intolerance to, imatinib
mesylate
Vivaglobin (immune globulin subcutaneous [human]), a new immune
globulin for the treatment of patients with primary immunodeficiency.
You뭠l find the most complete data on more than 4,000 drugs by brand
and generic name (both in the same convenient index), manufacturer,
and product category.
Your 2007 PDR provides usage information and warnings, drug
interactions, plus more than 2,000 full-size, full-color photos cross-
referenced to the drug. You will also find: > Phonetic spelling for
each listing > A key to controlled substances > Dosages > Clinical
pharmacology > FDA use-in-pregnancy ratings > Adverse reactions >
Contraindications > Pediatric use > And all other FDA-required
information --This text refers to the Library Binding edition